Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Cerilliant
Mallinckrodt
Johnson and Johnson
Covington
Federal Trade Commission
McKesson
Novartis
Medtronic
Harvard Business School

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020753

« Back to Dashboard

NDA 020753 describes AROMASIN, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from three suppliers. Additional details are available on the AROMASIN profile page.

The generic ingredient in AROMASIN is exemestane. There are fifteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the exemestane profile page.
Summary for 020753
Tradename:AROMASIN
Applicant:Pharmacia And Upjohn
Ingredient:exemestane
Patents:0
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details
Pharmacology for NDA: 020753
Mechanism of ActionAromatase Inhibitors
Suppliers and Packaging for NDA: 020753
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AROMASIN exemestane TABLET;ORAL 020753 NDA Pharmacia and Upjohn Company LLC 0009-7663 N 0009-7663-04
AROMASIN exemestane TABLET;ORAL 020753 NDA Physicians Total Care, Inc. 54868-5261 E 54868-5261-0

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Oct 21, 1999TE:ABRLD:Yes

Expired US Patents for NDA 020753

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn AROMASIN exemestane TABLET;ORAL 020753-001 Oct 21, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn AROMASIN exemestane TABLET;ORAL 020753-001 Oct 21, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Queensland Health
Teva
US Department of Justice
Accenture
Mallinckrodt
Moodys
Citi
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot